Comparison of three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40% versus ≥40% (from the HORIZONS-AMI Trial)

American Journal of Cardiology

Volumn 111, Issue 1, 2013, Pages 12-20

  Daneault, Benoit ^a,b   Généreux, Philippe ^a,b,c   Kirtane, Ajay J ^a,b   Witzenbichler, Bernhard ^d   Guagliumi, Giulio ^e   Paradis, Jean Michel ^a,b   Fahy, Martin P ^a,b   Mehran, Roxana ^b,f   Stone, Gregg W ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e OSPEDALI RIUNITI   (Italy)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; THIENOPYRIDINE DERIVATIVE; WARFARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; BARE METAL STENT; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE CLEARANCE; DRUG ELUTING STENT; FEMALE; HEART DISEASE; HEART INDEX; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICULOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MONOTHERAPY; MULTIVESSEL DISEASE; OPEN STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT DURATION;

AGED; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GATED BLOOD-POOL IMAGING; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84871017796     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.08.040     Document Type: Article

References (31)

1. G. De Luca Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge Circulation 109 2004 2737 2743
2. A. Halkin, M. Singh, E. Nikolsky, C.L. Grines, J.E. Tcheng, E. Garcia, D.A. Cox, M. Turco, T.D. Stuckey, Y. Na, A.J. Lansky, B.J. Gersh, W.W. O'Neill, R. Mehran, and G.W. Stone Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score J Am Coll Cardiol 45 2005 1397 1405
3. G. Marenzi, M. Moltrasio, E. Assanelli, G. Lauri, I. Marana, M. Grazi, M. Rubino, M. De Metrio, F. Veglia, and A.L. Bartorelli Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty Am Heart J 153 2007 755 762
4. V.S. DeGeare, J.A. Boura, L.L. Grines, W.W. O'neill, and C.L. Grines Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction Am J Cardiol 87 2001 1035 1038
5. A. Dziewierz, Z. Siudak, T. Rakowski, W. Zasada, J.S. Dubiel, and D. Dudek Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER registry) Am J Cardiol 106 2010 342 347
6. R.H. Mehta, W.W. O'neill, K.J. Harjai, D.A. Cox, B.R. Brodie, J. Boura, L. Grines, G.W. Stone, and C.L. Grines Primary Angioplasty in Myocardial Infarction (PAMI) and the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventions Am J Cardiol 97 2006 817 822
7. G.W. Stone, A.J. Lansky, S.J. Pocock, B.J. Gersh, G. Dangas, S.C. Wong, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, M. Möckel, A. Ochala, A. Kellock, H. Parise, R. Mehran Investigators H-AT Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
8. G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, A.J. Kirtane, H. Parise, R. Mehran Investigators H-AT Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
9. C.B. Granger, J.J. McMurray, S. Yusuf, P. Held, E.L. Michelson, B. Olofsson, J. Ostergren, M.A. Pfeffer, and K. Swedberg Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Lancet 362 2003 772 776
10. M.A. Pfeffer, E. Braunwald, L.A. Moye, L. Basta, E.J. Brown, T.E. Cuddy, B.R. Davis, E.M. Geltman, S. Goldman, G.C. Flaker, M. Klein, G.A. Lamas, M. Packer, J. Rouleau, J.L. Rouleau, J. Rutherford, J.H. Wertheimer, and C.M. Hawkins The SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial N Engl J Med 327 1992 669 677
11. B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, B. Roniker, R. Bittman, S. Hurley, J. Kleiman, and M. Gatlin Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
12. L. Kober, C. Torp-Pedersen, J.E. Carlsen, H. Bagger, P. Eliasen, K. Lyngborg, J. Videbaek, D.S. Cole, L. Auclert, and N.C. Pauly Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 333 1995 1670 1676
13. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, R. Boineau, M. Domanski, C. Troutman, J. Anderson, G. Johnson, S.E. McNulty, N. Clapp-Channing, L.D. Davidson-Ray, E.S. Fraulo, D.P. Fishbein, R.M. Luceri, and J.H. Ip Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
14. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, J.P. Daubert, S.L. Higgins, M.W. Brown, and M.L. Andrews Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
15. S.H. Hohnloser, K.H. Kuck, P. Dorian, R.S. Roberts, J.R. Hampton, R. Hatala, E. Fain, M. Gent, and S.J. Connolly Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction N Engl J Med 351 2004 2481 2488
16. G. Steinbeck, D. Andresen, K. Seidl, J. Brachmann, E. Hoffmann, D. Wojciechowski, Z. Kornacewicz-Jach, B. Sredniawa, G. Lupkovics, F. Hofgartner, A. Lubinski, M. Rosenqvist, A. Habets, K. Wegscheider, and J. Senges Defibrillator implantation early after myocardial infarction N Engl J Med 361 2009 1427 1436
17. B. Daneault, D.H. Do, A. Maltais, S. Berube, R. Harvey, A. Gervais, K. Dalery, and M. Nguyen Reduction of delays in primary percutaneous coronary intervention Can J Cardiol 27 2011 562 566
18. S. Sederholm Lawesson, T. Todt, J. Alfredsson, M. Janzon, U. Stenestrand, and E. Swahn Gender difference in prevalence and prognostic impact of renal insufficiency in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention Heart 97 2011 308 314
19. M.A. Cavender, S. Milford-Beland, M.T. Roe, E.D. Peterson, W.S. Weintraub, and S.V. Rao Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry) Am J Cardiol 104 2009 507 513
20. P. Sorajja, B.J. Gersh, D.A. Cox, M.G. McLaughlin, P. Zimetbaum, C. Costantini, T. Stuckey, J.E. Tcheng, R. Mehran, A.J. Lansky, C.L. Grines, and G.W. Stone Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction Eur Heart J 28 2007 1709 1716
21. B.E. Claessen, R.J. van der Schaaf, N.J. Verouden, N.K. Stegenga, A.E. Engstrom, K.D. Sjauw, W.J. Kikkert, M.M. Vis, J. Baan, K.T. Koch, R.J. de Winter, J.G. Tijssen, J.J. Piek, and J.P. Henriques Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention J Am Coll Cardiol Intv 2 2009 1128 1134
22. R.J. van der Schaaf, M.M. Vis, K.D. Sjauw, K.T. Koch, J. Baan, J.G.P. Tijssen, R.J. de Winter, J.J. Piek, and J.P.S. Henriques Impact of multivessel coronary disease on long-term mortality in patients with ST-elevation myocardial infarction is due to the presence of a chronic total occlusion Am J Cardiol 98 2006 1165 1169
23. R. Mehran, S. Pocock, E. Nikolsky, G.D. Dangas, T. Clayton, B.E. Claessen, A. Caixeta, F. Feit, S.V. Manoukian, H. White, M. Bertrand, E.M. Ohman, H. Parise, A.J. Lansky, A.M. Lincoff, and G.W. Stone Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events), ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy), and HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trials J Am Coll Cardiol Intv 4 2011 654 664
24. E.M. Antman, D.T. Anbe, P.W. Armstrong, E.R. Bates, L.A. Green, M. Hand, J.S. Hochman, H.M. Krumholz, F.G. Kushner, G.A. Lamas, C.J. Mullany, J.P. Ornato, D.L. Pearle, M.A. Sloan, and S.C. Smith Jr ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) J Am Coll Cardiol 44 2004 671 719
25. S. Homma, J.L. Thompson, P.M. Pullicino, B. Levin, R.S. Freudenberger, J.R. Teerlink, S.E. Ammon, S. Graham, R.L. Sacco, D.L. Mann, J.P. Mohr, B.M. Massie, A.J. Labovitz, S.D. Anker, D.J. Lok, P. Ponikowski, C.J. Estol, G.Y. Lip, M.R. Di Tullio, A.R. Sanford, V. Mejia, A.P. Gabriel, M.L. Del Valle, and R. Buchsbaum Warfarin and aspirin in patients with heart failure and sinus rhythm N Engl J Med 366 2012 1859 1869
26. J.L. Mega, E. Braunwald, S.D. Wiviott, J.P. Bassand, D.L. Bhatt, C. Bode, P. Burton, M. Cohen, N. Cook-Bruns, K.A. Fox, S. Goto, S.A. Murphy, A.N. Plotnikov, D. Schneider, X. Sun, F.W. Verheugt, and C.M. Gibson Rivaroxaban in patients with a recent acute coronary syndrome N Engl J Med 366 2012 9 19
27. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K.W. Mahaffey, B.M. Scirica, A. Skene, P.G. Steg, R.F. Storey, R.A. Harrington, A. Freij, and M. Thorsen Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
28. A.M. Feldman, H. Klein, P. Tchou, S. Murali, W.J. Hall, D. Mancini, J. Boehmer, M. Harvey, M.S. Heilman, S.J. Szymkiewicz, and A.J. Moss Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD Pacing Clin Electrophysiol 27 2004 4 9
29. L. Politi, F. Sgura, R. Rossi, D. Monopoli, E. Guerri, C. Leuzzi, F. Bursi, G.M. Sangiorgi, and M.G. Modena A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up Heart 96 2010 662 667
30. R. Kornowski, R. Mehran, G. Dangas, E. Nikolsky, A. Assali, B.E. Claessen, B.J. Gersh, S.C. Wong, B. Witzenbichler, G. Guagliumi, D. Dudek, M. Fahy, A.J. Lansky, and G.W. Stone Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial J Am Coll Cardiol 58 2011 704 711
31. E.L. Hannan, Z. Samadashvili, G. Walford, D.R. Holmes Jr, A.K. Jacobs, N.J. Stamato, F.J. Venditti, S. Sharma, and S.B. King III Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease J Am Coll Cardiol Intv 3 2010 22 31